Results 101 to 110 of about 492 (136)

Demographic characteristics of reports with TXA.

BackgroundTranexamic acid (TXA) is an antifibrinolytic agent commonly used to mitigate blood loss across various medical indications. Despite its widespread use, comprehensive data on its safety profile remain limited.
Jing Feng (177843), Chiwei Guo (22569722), Shujuan Zhao (6317975)   +2 more
core   +1 more source

Table1_A real-world study of antifibrotic drugs-related adverse events based on the United States food and drug administration adverse event reporting system and VigiAccess databases.docx

Objectives: This study aims to investigate adverse events (AEs) and adverse drug reactions (ADRs) associated with pirfenidone and nintedanib, two antifibrotic drugs used to treat idiopathic pulmonary fibrosis (IPF).Methods: Reporting odds ratio (ROR) and
Rurong Wang (11450419), Taoran Yang (18013756), Jian Zhou (28020), Xuehan Li (704130), Menglin He (12966119)   +4 more
core   +1 more source

IMPACTO DA UTILIZAÇÃO DA CLOROQUINA E HIDROXICLOROQUINA NO COMBATE À COVID-19: ESTUDO EXPLORATÓRIO DE REAÇÕES ADVERSAS.

, 2020
Introdução: Atualmente, não há uma farmacoterapia estabelecida para ser utilizada no tratamento ou prevenção da doença causada pelo Novo Coronavírus, a COVID-19, que apresente evidências científicas robustas e graus de recomendação aceitáveis. Entretanto,
ANA PAULA SOARES DE SENNA TEIXEIRA, Secretaria de Estado da Saúde do Paraná, SUÉLLYN MATTOS DE ARAGÃO, AMANDA DE CASSIA AZEVEDO DA SILVA, ANDRÉ LUIS CÂNDIDO DA SILVA   +4 more
core  

Inefectividad de medicamentos biológicos reportada como reacción adversa al Programa Mundial de Farmacovigilancia de la OMS

, 2019
149 páginas : gráficas, ilustracionesThe advances of science have achieved that the development of medicines is increased, finding diversity in manufacturing methods, where the different production processes in obtaining pharmacological assets are not ...
Daza Olaya, Jeimmy Stephanie, Benavides, Andrés David   +1 more
core   +1 more source

VigiAccess: Promoting public access to VigiBase

Indian Journal of Pharmacology, 2016
openaire   +3 more sources

A Real-World Data Analysis of Adverse Drug Reactions Associated with Neuroprotective Agents: Insights from WHO-VigiAccess

Abstract Introduction: Sensorineural hearing loss (SNHL) is a common sensory disorder characterized by auditory nerve damage and cochlear dysfunction, often driven by oxidative stress, excitotoxicity, and neuroinflammation. Neuroprotective agents such as Cerebrolysin, Citicoline, Flunarizine, and Mecobalamin have demonstrated efficacy in ...
Shuainan Chen, Yurui Zhuang, Rujie Li, Chuan Chang, Guojun Zheng   +4 more
openaire   +1 more source

Estudio descriptivo de reacciones adversas con Sildenafil reportados al programa Mundial de farmacovigilancia de la OMS del año 1998 a Septiembre de 2019

, 2020
102 páginas : gráficasIn the descriptive study of adverse reactions with sildenafil reported to the WHO global pharmacovigilance program from 1998 to September 2019, 53,219 cases of possible RAMs with sildenafil were analyzed, corresponding to 89,175 ...
Morales Andrade, Viviana Cristina, Parra Avila, Yira Consuelo   +1 more
core  

Global pharmacovigilance overview of adverse drug reactions associated with propofol: A descriptive pharmacovigilance study using WHO-VigiAccess data. [PDF]

Medicine (Baltimore)
Alorfi NM, Aldabbagh A, Alourfi MM, Alghamdi WS, Al Ghamdi SS, Niyazi AA, Aldekhail NM, Alkhanani MF, Ibrahim NA, Alansari AM, Ali TO, Alsolami FA, Zarroug SHO, Abdalla HK.   +13 more
europepmc   +1 more source

Pregabalin-associated adverse drug reactions: A real-world pharmacovigilance study using WHO-VigiAccess. [PDF]

Medicine (Baltimore)
Alshehri FS, Ashour AM, Alorfi NM, Alshehri AS, Almahdi MK, Almowallad FM.   +5 more
europepmc   +1 more source

Post-marketing safety assessment of tetrandrine based on the WHO-VigiAccess database. [PDF]

Medicine (Baltimore)
Zhong Y, Tan X, Fang C.
europepmc   +1 more source